Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients.
about
Low-level human equivalent gestational lead exposure produces supernormal scotopic electroretinograms, increased retinal neurogenesis, and decreased retinal dopamine utilization in ratsVisual perception and its impairment in schizophreniaMelatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor SymptomsPerception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS.Retinal Ganglion Cells and Circadian Rhythms in Alzheimer's Disease, Parkinson's Disease, and BeyondEffects of smoking and smoking abstinence on spatial vision in chronic heavy smokers.Apomorphine induced cognitive changes in Parkinson's disease.Parkinson's disease and neuropsychological assessment.Mechanisms underlying gait disturbance in Parkinson's disease: a single photon emission computed tomography study.Deficient visual sensitivity in schizotypal personality disorder.Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography.Perimetric and retinal nerve fiber layer findings in patients with Parkinson's diseasePathophysiology and treatment of psychosis in Parkinson's disease: a review.Discharge responses of the optic tract to flash stimuli in Parkinson's diseaseParallel basal ganglia circuits for voluntary and automatic behaviour to reach rewardsPsychosis in Parkinson's disease.Ophthalmology issues in schizophrenia.Schizophrenia and the eye.Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson's disease.Alpha synuclein gene expression profile in the retina of vertebratesRetinal dopamine mediates multiple dimensions of light-adapted vision.Veering in hemi-Parkinson's disease: Primacy of visual over motor contributionsConsequences of variations in genes that affect dopamine in prefrontal cortexFrom neuroscience to application in neuropharmacology: A generation of progress in electrophysiology.Light- and dopamine-regulated receptive field plasticity in primate horizontal cellsNew approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins.Relation of Parkinson's disease subtypes to visual activities of daily living.The phenomenon of drug craving.'Gamma' band oscillatory response to chromatic stimuli in volunteers and patients with idiopathic Parkinson's disease.Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis.Potential role of retina as a biomarker for progression of Parkinson's disease.A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease.Non-motor features of Parkinson disease.The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma.Contrast sensitivity in children with and without attention deficit hyperactivity disorder symptoms.Electroretinogram and cue-elicited craving in withdrawn cocaine-dependent patients: a replication.Neurochemical Systems of the Retina Involved in the Control of Movement.Visual Hallucinations as Incidental Negative Effects of Virtual Reality on Parkinson's Disease Patients: A Link with Neurodegeneration?Selective effects of low doses of apomorphine on spatiotemporal contrast sensitivity in healthy volunteers: a double-blind placebo-controlled studyComparison of color discrimination in chronic heavy smokers and healthy subjects.
P2860
Q23912158-8C2FF78E-63B1-44A8-A546-23C20F48960DQ24651844-BCFADDC7-3E09-4150-A540-C8A1186FC46FQ28075345-6FB70EAD-7182-4AFE-AC0D-3B6363FBCFD2Q30491461-8E2EE65F-C04A-48C4-9FC7-B5F0DF663729Q33634088-009EE130-FAAD-4A28-881E-242641DA522AQ33686880-59090C1B-CFE8-4CA9-B652-964442843288Q33732970-5135CCD4-E543-4241-8C29-F2FC929019BCQ33737505-E1BBF591-BD95-4E89-BE84-80AD8C3237AFQ33866587-0FCAC71B-277F-40CA-9B36-74D8CC15D7CEQ34249669-0C778B1F-10D6-4F13-A1DC-953C03C0E6DCQ34399834-2031AD3B-7958-4918-9914-4555B0529D9BQ34432056-916D44A9-836C-4CBE-A738-5B6A9EA678D5Q34610608-22668808-E5C3-49A8-B99C-E0AFC258A2A6Q34936735-E807A268-285C-46A0-AF8A-5D3A66C818A6Q35821216-16A1CEC6-3CDC-4199-A65A-1D3291732A09Q35863404-CCA33782-B8A6-4BAF-B873-0F556291BFF9Q35912687-D48C5D74-FF30-4EC0-9604-F069D6451C9AQ36025373-937A7243-02DE-402C-AC16-A7161005BFDCQ36026662-75EA3125-6153-4562-BBFC-ADE5F75103B4Q36050277-2F548B0D-8019-4FDE-9105-92802C17C970Q36104677-E884E0CE-ECA7-4CDA-B4C2-A67BC7DC54C5Q36120966-DEC85FB9-7C3C-40B3-B249-9F5CC5A2D735Q36453838-96BB9136-4670-4826-8365-20638EDD6D98Q36492225-81695B5D-E16D-482D-8009-A0971B8C760AQ36784542-39576544-3CDF-4919-88A1-A5CC1647894CQ37021326-3B95478C-8A66-437C-BC08-1CAA4A787581Q37136551-6BD26EFD-D50A-4EF2-BB0D-60F7E876F1C3Q37323852-DBCB07C8-C131-4F1F-95FA-20E0430AC06DQ37383934-B5D3DB90-CEFE-4915-AFBB-8F914D34225AQ37499629-3200ECD2-EF44-4FE7-8378-F96868B43528Q38007166-EA81FE96-93F1-42AC-A76B-2BE99CE1CE21Q38662579-F416D71C-7E95-4BBF-B377-C66A586C5F54Q39358549-39634405-83E8-43A4-8AC5-79C86966B93CQ39449147-56C86EC0-9198-4F9E-B678-D0573FBC7612Q39921229-8B63122C-70FA-45AB-9AC5-DD8845F87781Q40701132-D21EF543-FD42-4946-97C5-CAAA278AFECBQ40964593-4EDD57F2-6613-4195-BE22-939D68DF45F8Q40996174-A8C86BB8-0C6F-4C65-9BE7-C4CD870C2AF2Q41172005-A2E3B2A3-17E4-4DC9-8ACE-DBA5E086070FQ41589125-EC8D664D-E345-4B6A-B169-F67C3AE5EF69
P2860
Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Visual deficits related to dop ...... Parkinson's disease patients.
@ast
Visual deficits related to dop ...... Parkinson's disease patients.
@en
type
label
Visual deficits related to dop ...... Parkinson's disease patients.
@ast
Visual deficits related to dop ...... Parkinson's disease patients.
@en
prefLabel
Visual deficits related to dop ...... Parkinson's disease patients.
@ast
Visual deficits related to dop ...... Parkinson's disease patients.
@en
P1476
Visual deficits related to dop ...... Parkinson's disease patients.
@en
P2093
Bodis-Wollner I
P304
P356
10.1016/0166-2236(90)90113-O
P577
1990-07-01T00:00:00Z